Pivotal bioVenture Partners Investment Advisor LLC Long-Term Concentrated

CIK: 0001844645 · Show all filings

Period: Q4 2021 (← Previous) (Next →)

Filing Date: Feb 14, 2022

Total Value ($000): $239,161 (100.0% shares, 0.0% debt)

Holdings (10)

— KARUNA THERAPEUTICS INC 46.7%

Value ($000) $111,705 Shares 852,708 Est. Cost $101.59 Unrealized —

PCVX VAXCYTE INC 11.1%

Value ($000) $26,442 Shares 1,111,485 Est. Cost $37.18 Unrealized -37.4%

— RALLYBIO CORP 9.1%

Value ($000) $21,668 Shares 2,271,311 Est. Cost $17.58 Unrealized —

— EXSCIENTIA PLC 6.4%

Value ($000) $15,260 Shares 772,285 Est. Cost $19.76 Unrealized —

— AKOUOS INC 6.4%

Value ($000) $15,250 Shares 1,794,088 Est. Cost $19.83 Unrealized —

ARQT ARCUTIS BIOTHERAPEUTICS INC 4.9%

Value ($000) $11,802 Shares 569,041 Est. Cost $24.49 Unrealized -18.7%

— INOZYME PHARMA INC 4.5%

Value ($000) $10,852 Shares 1,591,154 Est. Cost $20.64 Unrealized —

— ALIGOS THERAPEUTICS INC 4.4%

Value ($000) $10,405 Shares 876,548 Est. Cost $27.65 Unrealized —

— BOLT BIOTHERAPEUTICS INC 3.9%

Value ($000) $9,268 Shares 1,891,467 Est. Cost $32.91 Unrealized —

— FUSION PHARMACEUTICALS INC 2.7%

Value ($000) $6,509 Shares 1,598,377 Est. Cost $11.75 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	KARUNA THERAPEUTICS INC	852,708	$111,705	46.7%	$101.59	—	COM	48576A100
PCVX	VAXCYTE INC	1,111,485	$26,442	11.1%	$37.18	-37.4%	COM	92243G108
—	RALLYBIO CORP	2,271,311	$21,668	9.1%	$17.58	—	COM	75120L100
—	EXSCIENTIA PLC	772,285	$15,260	6.4%	$19.76	—	ADS	30223G102
—	AKOUOS INC	1,794,088	$15,250	6.4%	$19.83	—	COM	00973J101
ARQT	ARCUTIS BIOTHERAPEUTICS INC	569,041	$11,802	4.9%	$24.49	-18.7%	COM	03969K108
—	INOZYME PHARMA INC	1,591,154	$10,852	4.5%	$20.64	—	COM	45790W108
—	ALIGOS THERAPEUTICS INC	876,548	$10,405	4.4%	$27.65	—	COM	01626L105
—	BOLT BIOTHERAPEUTICS INC	1,891,467	$9,268	3.9%	$32.91	—	COM	097702104
—	FUSION PHARMACEUTICALS INC	1,598,377	$6,509	2.7%	$11.75	—	COM	36118A100